FDMT - 4D Molecular Therapeutics, Inc.
IEX Last Trade
5.55
0.010 0.180%
Share volume: 12,014
Last Updated: Fri 27 Dec 2024 08:30:30 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$5.54
0.01
0.18%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-08 | 2023-03-15 | 2023-05-11 | 2023-08-09 | 2023-11-09 | 2024-02-29 | 2024-05-09 | |
| Total revenue | 162.000 K | 500.000 K | 1.248 M | 298.000 K | 239.000 K | 20.204 M | -18.000 K | 28.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 162.000 K | 500.000 K | 1.248 M | 298.000 K | 239.000 K | 20.204 M | -18.000 K | 28.000 K | |
| 208.64% | 149.60% | -76.12% | -19.80% | 8,353.56% | -100.09% | 255.56% | |||
| Operating expenses | 28.588 M | 26.995 M | 29.967 M | 30.404 M | 32.375 M | 34.178 M | 36.633 M | 38.164 M | |
| Selling general and admin | 8.166 M | 8.055 M | 8.457 M | 7.992 M | 8.791 M | 9.112 M | 10.599 M | 10.294 M | |
| Research and development | 20.422 M | 18.940 M | 21.510 M | 22.412 M | 23.584 M | 25.066 M | 26.034 M | 27.870 M | |
| Total expenses | 28.588 M | 26.995 M | 29.967 M | 30.404 M | 32.375 M | 34.178 M | 36.633 M | 38.164 M | |
| -5.57% | 11.01% | 1.46% | 6.48% | 5.57% | 7.18% | 4.18% | |||
| Operating income | -28.426 M | -26.495 M | -28.719 M | -30.106 M | -32.136 M | -13.974 M | -36.651 M | -38.136 M | |
| Ebit | -28.426 M | -26.495 M | -28.719 M | -30.106 M | -32.136 M | -13.974 M | -36.651 M | -38.136 M | |
| Pretax income | -28.086 M | -25.691 M | -27.379 M | -28.682 M | -29.616 M | -10.256 M | -32.283 M | -32.401 M | |
| -8.53% | 6.57% | 4.76% | 3.26% | -65.37% | 214.77% | 0.37% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -28.086 M | -25.691 M | -27.379 M | -28.682 M | -29.616 M | -10.256 M | -32.283 M | -32.401 M | |
| 8.53% | -6.57% | -4.76% | -3.26% | 65.37% | -214.77% | -0.37% | |||
| Net income | -28.086 M | -25.691 M | -27.379 M | -28.682 M | -29.616 M | -10.256 M | -32.283 M | -32.401 M | |
| 8.53% | -6.57% | -4.76% | -3.26% | 65.37% | -214.77% | -0.37% |